Insulin and Cardiovascular Disease: Pressure on the Pipes

Insulin resistance does not stay confined to fat cells.

Once insulin signaling becomes impaired, its effects extend across vascular, lipid, and inflammatory systems.

In blood vessels, insulin normally supports endothelial function by stimulating nitric oxide production, allowing arteries to relax and regulate blood flow. With insulin resistance, this signal weakens. Vessels become less responsive, vascular tone stiffens, and blood pressure regulation deteriorates over time.

In the liver, chronically elevated insulin alters lipid handling. Instead of promoting efficient fat oxidation and export, the liver increases triglyceride production and release into circulation while HDL levels often decline. Lipid particles become more atherogenic, increasing cardiovascular risk.

In fat tissue, insulin’s dominant effect is fat retention. By suppressing hormone sensitive lipase, insulin prevents stored fat from being released even when energy demand exists. Visceral fat depots expand and actively contribute to inflammatory signaling that further worsens insulin sensitivity.

At the same time, persistent insulin exposure promotes low grade inflammation and oxidative stress, placing additional strain on vascular tissue and accelerating metabolic dysfunction.

This is why heart disease clusters so tightly with diabetes, abdominal obesity, and metabolic syndrome.

Different pipes.
Same pressure source.